体重指数对胸肌前乳房再造术后结局的影响
本研究纳入197例患者共366个再造乳房,按体重指数分为五组,比较胸肌前再造术后并发症。宽泛分类下各组并发症率无显著差异;五组分层时II/III度肥胖者再手术、假体丢失、皮瓣坏死、伤口裂开及总体并发症率高于超重组,但多因素回归显示体重指数连续变量不独立预测任何并发症,糖尿病和吸烟才是显著预测因素。
要点
- 体重指数单独不预测胸肌前再造术后并发症,不应据此排除患者。
- 糖尿病和吸烟是任何并发症的显著预测因素。
- II/III度肥胖者部分并发症率高于超重组,但非体重指数独立效应。
核心结论
- 体重指数单独不是胸肌前扩张器/假体乳房再造术后结局的预测因素,不应用于估计术后并发症风险或排除患者接受胸肌前再造。
研究设计与样本
- 回顾性研究,纳入197例患者共366个再造乳房,按体重指数分为正常、超重、I度肥胖、II度肥胖、III度肥胖五组,比较术后并发症。
- 另采用非肥胖与肥胖、正常/超重/肥胖的宽泛分类进行分析,并用多因素logistic回归评估体重指数作为并发症独立预测因素。
主要发现
- 采用宽泛分类时,各体重指数组间并发症率无显著差异。
- 五组分层时,II度和/或III度肥胖患者相比超重患者,再手术、扩张器/假体丢失、皮肤坏死、伤口裂开及总体并发症率显著更高。
- 多因素logistic回归中,体重指数作为连续变量不独立预测任何并发症。
- 糖尿病和吸烟是任何并发症的显著预测因素,提示这些因素而非体重指数驱动了高体重指数组并发症率升高。
关键数值与推荐
- 证据等级:风险,II级。
临床怎么用
- 临床不应仅凭体重指数估计胸肌前乳房再造术后并发症风险或排除患者。
- 应重点评估并优化糖尿病和吸烟等合并因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Body mass index has been shown to be a predictor of outcomes after subpectoral expander/implant reconstruction, with every unit increase in body mass index increasing the risk of complications by approximately 6 percent. The effect of body mass index on complications after prepectoral reconstruction has not yet been evaluated and is the purpose of this study. METHODS: A total of 366 reconstructed breasts from 197 patients were stratified into five body mass index groups (normal; overweight; and class I, class II, and class III, obese) and postoperative complications were compared across the groups. Additional analyses were performed using broad classifications of body mass index into nonobese and obese in addition to normal, overweight, and obese. Body mass index as an independent predictor of complications was assessed using multivariate logistic regression analysis. RESULTS: Complication rates did not differ significantly across body mass index groups when using the broad classifications. With five-group stratification, significantly higher rates of return to operating room, expander/implant loss, skin necrosis, wound dehiscence, and overall complications were seen in class II and/or class III obese versus overweight patients. However, on multivariate logistic regression analyses, body mass index, as a continuous variable, did not independently predict any complication. Diabetes and smoking emerged as significant predictors of any complication, indicating that these factors, rather than body mass index, were driving the increased rates of complications seen in the high-body mass index groups. CONCLUSION: Body mass index alone is not a predictor of outcomes after prepectoral expander/implant breast reconstruction and should not be used to estimate risk of postoperative complications or exclude patients for prepectoral reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.
引用
- Gabriel A, Sigalove S, Sigalove NM, et al. Effect of Body Mass Index on Outcomes after Prepectoral Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 31461000. doi:10.1097/PRS.0000000000005901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。